Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1432 views | HTML 1823 views | ?
Hua-Dong Zhao1,*, Hai-Li Tang1,*, Ning-Ning Liu2,*, Ya-Li Zhao2,*, Qin-Qin Liu2, Xiao-Shan Zhu2, Lin-Tao Jia3, Chun-Fang Gao2, An-Gang Yang4, Jun-Tang Li2,3,4
1Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
2Centre of Inflammation and Cancer Research, 150th Central Hospital of PLA, Luoyang, Henan 471031, China
3State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
4State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
*These authors contributed equally to this work
Jun-Tang Li, e-mail: [email protected]
An-Gang Yang, e-mail: [email protected]
Keywords: anaplastic thyroid carcinoma, ubiquitin-specific protease 22, proliferation, invasion, apoptosis
Received: January 14, 2016 Accepted: April 11, 2016 Published: April 29, 2016
Ubiquitin-specific protease 22 (USP22) aberrance has been implicated in several malignancies; however, whether USP22 plays a role in anaplastic thyroid carcinoma (ATC) remains unclear. Here, we report that USP22 expression is highly elevated in ATC tissues, which positively correlated with tumor size, extracapsular invasion, clinical stages, and poor prognosis of ATC patients. In vitro assays showed that USP22 depletion suppressed ATC cell survival and proliferation by decreasing Rb phosphorylation and cyclin D2, inactivating Akt, and simultaneously upregulating Rb; USP22 silencing restrained cell migration and invasion by inhibiting epithelial-mesenchymal transition; USP22 knockdown promoted mitochondrion- mediated and caspase-dependent apoptosis by upregulating Bax and Bid and promoting caspase-3 activation. Consistent with in vitro findings, downregulation of USP22 in ATC cells impeded tumor growth and lung metastasis in vivo. These results raise the applicability for USP22 as a useful predictor of ATC prognosis and a potential therapeutic target for ATC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.